Overview
Matthew Samec is a Rheumatologist in Atlantic, Iowa. Dr. Samec is rated as an Advanced provider by MediFind in the treatment of VEXAS Syndrome. His top areas of expertise are VEXAS Syndrome, Juvenile Temporal Arteritis, Giant Cell Arteritis (GCA), and Temporal Arteritis. Dr. Samec is currently accepting new patients.
His clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of VEXAS Syndrome.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
Locations
1501 E 10th St, Suite 200, Atlantic, IA 50022
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Alegent Creighton Clinic
Jay Kenik is a Rheumatologist in Omaha, Nebraska. Dr. Kenik is rated as a Distinguished provider by MediFind in the treatment of VEXAS Syndrome. His top areas of expertise are Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Fibromyalgia. Dr. Kenik is currently accepting new patients.
Unmc Physicians
Alan Erickson is a Rheumatologist in Omaha, Nebraska. Dr. Erickson is rated as an Advanced provider by MediFind in the treatment of VEXAS Syndrome. His top areas of expertise are Rheumatoid Arthritis (RA), Undifferentiated Connective Tissue Disease (UCTD), Systemic Lupus Erythematosus (SLE), and Polymyalgia Rheumatica.
Alegent Creighton Clinic
Joseph Nahas is a Rheumatologist in Omaha, Nebraska. Dr. Nahas is rated as a Distinguished provider by MediFind in the treatment of VEXAS Syndrome. His top areas of expertise are Rheumatoid Arthritis (RA), Necrotizing Vasculitis, Giant Cell Arteritis (GCA), and Juvenile Temporal Arteritis. Dr. Nahas is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- VEXAS SyndromeDr. Samec isAdvanced. Learn about VEXAS Syndrome.
- Experienced
- Giant Cell Arteritis (GCA)Dr. Samec isExperienced. Learn about Giant Cell Arteritis (GCA).
- Juvenile Temporal ArteritisDr. Samec isExperienced. Learn about Juvenile Temporal Arteritis.
- Necrotizing VasculitisDr. Samec isExperienced. Learn about Necrotizing Vasculitis.
- OsteoporosisDr. Samec isExperienced. Learn about Osteoporosis.
- PolymyositisDr. Samec isExperienced. Learn about Polymyositis.
- Postmenopausal OsteoporosisDr. Samec isExperienced. Learn about Postmenopausal Osteoporosis.